Search by Drug Name or NDC

    NDC 00597-0270-12 Jentadueto XR 2.5; 1000 mg/1; mg/1 Details

    Jentadueto XR 2.5; 1000 mg/1; mg/1

    Jentadueto XR is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is LINAGLIPTIN; METFORMIN HYDROCHLORIDE.

    Product Information

    NDC 00597-0270
    Product ID 0597-0270_d3b76cb1-ca66-412d-b028-41ab7ee3f92f
    Associated GPIs 27992502407520
    GCN Sequence Number 076256
    GCN Sequence Number Description linagliptin/metformin HCl TAB BP 24H 2.5-1000MG ORAL
    HIC3 C4F
    HIC3 Description ANTIHYPERGLYCEMIC,DPP-4 INHIBITOR-BIGUANIDE COMBS.
    GCN 41637
    HICL Sequence Number 038464
    HICL Sequence Number Description LINAGLIPTIN/METFORMIN HCL
    Brand/Generic Brand
    Proprietary Name Jentadueto XR
    Proprietary Name Suffix n/a
    Non-Proprietary Name linagliptin and metformin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 2.5; 1000
    Active Ingredient Units mg/1; mg/1
    Substance Name LINAGLIPTIN; METFORMIN HYDROCHLORIDE
    Labeler Name Boehringer Ingelheim Pharmaceuticals, Inc.
    Pharmaceutical Class Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208026
    Listing Certified Through 2024-12-31

    Package

    NDC 00597-0270-12 (00597027012)

    NDC Package Code 0597-0270-12
    Billing NDC 00597027012
    Package 1 BOTTLE in 1 CARTON (0597-0270-12) / 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
    Marketing Start Date 2016-05-27
    NDC Exclude Flag N
    Pricing Information N/A